New South San Francisco center showcases how cutting-edge cryo-electron microscopy is transforming and accelerating drug discoverySOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific ...
The new center offers immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights.
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
French preclinical CRO NovAliX has found a new partner across the pond. Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with ...
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter ...
Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...
The MarketWatch News Department was not involved in the creation of this content. Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 ...
AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...
Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
This article is based on a poster originally authored by Daniel A. Barr, Mario Öeren, Peter A. Hunt, Jonathan D. Tyzack, Tomáš Chrien, Tamsin E. Mansley and Matthew D. Segall, which was presented at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results